References
- American Heart Association [Internet]. Dallas TX: AHA; c2017. Types of blood pressure medications. American Heart Association; 2017 Oct 31 [cited 2021 Jun 6]; Available from: https://www.heart.org/en/health-topics/high-blood-pressure/changes-you-can-make-to-manage-high-blood-pressure/types-of-blood-pressure-medications
- Singer JR, Pearce ZD, Westhouse SJ, Siebert KJ. Uveal effusion as a mechanism of bilateral angle-closure glaucoma induced by chlorthalidone. J Of Glaucoma. Jan, 2015;24(1):84–86. doi:10.1097/IJG.0000000000000037.
- Winter G, Schaudig U, Stemplewitz B. Bilateral effusion syndrome induced by chlorthalidon. Der Ophthalmologe. 2021 Apr 15;118(3):273–275. doi:10.1007/s00347-020-01091-9.
- Geanon JD, Perkins TW. Bilateral acute angle-closure glaucoma associated with drug sensitivity to hydrochlorothiazide. Arch Ophthalmol. 1995;113(10):1231–1232. doi:10.1001/archopht.1995.01100100019012.
- Boundaoui ON, Woodruff TE. Presumed furosemide-associated bilateral angle-closure glaucoma. J Of Glaucoma. Aug, 2016;25(8):748–750. doi:10.1097/IJG.0000000000000430.
- European Medicines Agency. EMA;c2020. New product information wording – extracts from PRAC recommendations on signals; 2020 Apr 6 [cited 2021 Jun 7]; Available from: https://www.ema.europa.eu/en/documents/other/new-product-information-wording-extracts-prac-recommendations-signals-adopted-9-12-march-2020-prac_en.pdf
- Government of Canada. Health Canada. Summary safety review – Diuretics, including acetazolamide-containing products; 2021 Mar 18 [cited 2021 Jun 70; Available from: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00261.
- Essebag V, Platt R, Abrahamowicz M, et al. Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol. 2005;5(1):5. doi:10.1186/1471-2288-5-5.
- Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 2004;111(7):109–111. doi:10.1016/j.ophtha.2003.04.004.
- Bae HW, Lee N, Lee HS, et al. Systemic hypertension as a risk factor for open-angle glaucoma: a meta-analysis of population-based studies. PLoS One. Published 2014 Sep 25 2014;9(9):e108226. doi:10.1371/journal.pone.0108226.
- Lee GC, Tam CP, Danesh-Meyer HV, Myers JS, Katz LJ. Bilateral angle closure glaucoma induced by sulphonamide-derived medications. Clin Exp Ophthalmol. Feb, 2007;35(1):55–58. doi:10.1111/j.1442-9071.2006.01365.x.
- Razeghinejad MR, Meyers JS, Katz LJ. Iatrogenic glaucoma secondary to medications. Am J Med. Jan, 2011;124(1):20–25. doi:10.1016/j.amjmed.2010.08.011.
- Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. Mar, 2007;18(2):129–133. doi:10.1097/ICU.0b013e32808738d5.
- Senthil S, Garudadri C, Rao HBL, Maheshwari R. Bilateral simultaneous acute angle closure caused by sulphonamide derivatives: a case series. Indian, J Ophthalmol. 2010 May-Jun;58(3):248–252. doi:10.4103/0301-4738.62657.
- Mancino R, Varesi C, Cerulli A, Aiello F, Nucci C. Acute bilateral angle-closure glaucoma and choroidal effusion associated with acetazolamide administration after cataract surgery. J Of Cat And Refractive Surgery. Feb, 2011;37(2):415–417. doi:10.1016/j.jcrs.2010.12.032.